Agios Pharmaceuticals Inc (AGIO)
32.94
+0.48
(+1.48%)
USD |
NASDAQ |
May 09, 16:00
32.91
-0.03
(-0.09%)
Pre-Market: 20:00
Agios Pharmaceuticals Gross Profit (TTM): 26.45M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 26.45M |
December 31, 2023 | 23.94M |
September 30, 2023 | 21.32M |
June 30, 2023 | 17.56M |
March 31, 2023 | 17.10M |
December 31, 2022 | 12.54M |
September 30, 2022 | 8.639M |
June 30, 2022 | 5.64M |
March 31, 2022 | 0.493M |
December 31, 2021 | 0.00 |
September 30, 2021 | |
June 30, 2021 |
Date | Value |
---|---|
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 110.75M |
June 30, 2019 | 99.62M |
March 31, 2019 | 114.12M |
December 31, 2018 | 92.99M |
September 30, 2018 | 73.48M |
June 30, 2018 | 70.33M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Dec 2021
110.75M
Maximum
Sep 2019
28.67M
Average
17.33M
Median
Gross Profit (TTM) Benchmarks
Alnylam Pharmaceuticals Inc | 1.682B |
Amgen Inc | 19.60B |
Blueprint Medicines Corp | 273.65M |
Corcept Therapeutics Inc | 515.90M |
Ionis Pharmaceuticals Inc | 766.68M |